Supreme Court’s Directive on Zydus’ Breast Cancer Biosimilar Sparks Industry Concerns Sub : Sci Sec: Health Why in News The legal case involving Zydus Life sciences’ biosimilar drug Sigrima, a generic version of Roche’s breast cancer treatment Pertuzumab, has taken a new direction following a Supreme Court decision. The case raises important concerns […]